1.Facial nerve decompression in Melkersson-rosenthal syndrome.
Seong Soo BAN ; Hee Yoon KOO ; Kwang Ik KO ; Hee Wan PARK ; Kwang Ryun KO
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(5):903-908
No abstract available.
Decompression*
;
Facial Nerve*
;
Melkersson-Rosenthal Syndrome*
2.Incidence estimation of leukemia among Korean children.
Hong Hoe KOO ; Hee Young SHIN ; Hyo Seop AHN ; Yoon Ok AHN
Journal of the Korean Pediatric Society 1992;35(1):80-87
No abstract available.
Child*
;
Humans
;
Incidence*
;
Leukemia*
3.CT in the diagnosis of pancreatic trauma.
Duk Ja BANG ; On Koo CHO ; Yong Soo KIM ; Yoon Young CHOI ; Byung Hee KOH
Journal of the Korean Radiological Society 1992;28(4):582-588
The incidence of pancreatic trauma is increasing and still remains a major source of morbidity and mortality. We have graded the pancreatic trauma on CT according to its pattern into four grades. We also determine the accuracy of CT in the evaluation of pancreatic trauma and the role of CT for delineation of pancretic ductal injury which is critical factor in outcome of pancreatic trauma. CT correctly diagnosed the pancreatic trauma and its traumatic pattern and severity in 22 of 25 cases. Pancreatic enlargement was the most common findings observed in 19 cases. Other findings were 15 cases of intrapancreatic low density hematoma, 12 cases of parenchymal fracture which were predilected in pancreatic neck area. CT grade III and IV could predict the pancreatic ductal injury, and was well correlated with severity of posttraumatic pancreatitis, duration of admission days and incidence of complications. So we concluded that CT can play a definite role for diagnosing and determining the prognosis of pancreatic trauma.
Diagnosis*
;
Hematoma
;
Incidence
;
Mortality
;
Neck
;
Pancreatic Ducts
;
Pancreatitis
;
Prognosis
4.Correlation Between the Frequency of Apoptotic Bodies and Gleason Scores in Prostatic Cancer.
Hee Soo YOON ; Ho Jung KIM ; Hea Soo KOO ; Ok Kyung KIM ; Sung Sook KIM
Korean Journal of Pathology 1997;31(5):462-469
Apoptosis (or programmed cell death) is defined by morphologic changes induced by a spectrum of physical and chemical agents. resulting in non-pathologic cell loss, which is relevant to a range of biological processes, including differentiation, development, maturation, and injury of cells as well as immunologic function. In this study, we examined the frequency of apoptotic bodies and mitoses (apoptotic and mitotic indices) in the tissue samples of 35 patients of prostatic carcinoma, which were grouped according to the Gleason scores, and 5 cases of benign prostatic hyperplasia. The indices were determined as the numbers of apoptotic and mitotic bodies per 100 tumor cells in hematoxylin eosin stained section. The apoptotic bodies were confirmed by the in situ nick end labelling method. The apoptotic and mitotic indices were observed more frequently in prostatic carcinoma than the benign hyperplastic prostatic tissues with a positive correlation between the frequency of apoptotic bodies and Gleason scores in prostatic cancer. In conclusion, an increased programmed cell death was correlated with the increasing malignant potential (higher Gleason scores) in prostatic cancer.
Apoptosis
;
Biological Processes
;
Cell Death
;
Eosine Yellowish-(YS)
;
Hematoxylin
;
Humans
;
In Situ Nick-End Labeling
;
Mitosis
;
Mitotic Index
;
Neoplasm Grading
;
Prostatic Hyperplasia
;
Prostatic Neoplasms*
5.Inferior vena cava thrombosis: US and CT evaluation.
On Koo CHO ; Yoon Young CHOI ; Yong Soo KIM ; Byung Hee KOH ; Heung Suk SEO
Journal of the Korean Radiological Society 1993;29(1):69-76
Forty five patients with inferior vena cava (IVC) thrombosis were studied with the use of ultrasonography (US) and computed tomography (CT). Thirty seven cases were cased by tumor extension and the primary neoplasms were hepatocellular Ca. (26cases), renal cell Ca. (6 cases), Wilms' tumor (1 case), IVC leiomyosarcoma (1 case) and retroperitoneal metastatic tumor (3 cases). Non-tumor thrombus were 8 cases which included 5 cases of Budd-Chiari syndrome and 3 cases of thrombophlebitis. US and CT both were good for the diagnosis of IVC thrombosis. Cranial extension was better demonstrated by US whereas CT yielded better delineation of the lower extension. Even though, differentiation of tumor non-tumor thrombi by the echogenecity and density of the thrombus was not possible, the finkdings of adjacent tumor mass, complete obstructive thrombus within dilated lumen with bulging wall, and nontapered acute margin of thrombus made the possibility of tumor thrombus more likely.
Budd-Chiari Syndrome
;
Diagnosis
;
Humans
;
Leiomyosarcoma
;
Thrombophlebitis
;
Thrombosis*
;
Ultrasonography
;
Vena Cava, Inferior*
;
Wilms Tumor
6.Redisplacement after Operative Reduction of Spondylolisthesis: Comparison between Pedicle screw system and Luque ring system.
Jae Lim CHO ; Won Koo YOON ; Ye Soo PARK ; Kyeong Jin CHOI ; Joo Hee HAN
The Journal of the Korean Orthopaedic Association 1997;32(5):1162-1172
Operative reduction is not essential for mild to moderate spondylolisthesis, but some authors agree that reduction of spondylolisthesis is beneficial for widening of intervertebral canal and consequently for decompression of neural tissue even though the degree of slippage is grade I or II. In our institute, we sometimes reduced the slippage for these reasons. But at follow up study we would find redisplacement and the degree of it seemed to be associated with the kind of instruments. So we analyzed redisplacement rate according to the kind of instruments in 59 cases of spondylolisthesis that were followed more than one year. The conclusions were as follow; 1. There was no significant correlation between reduction and redisplacement rate with pathologic type, lesion site, age,iscectomy and clinical result at least in grade I or II spondylolisthesis (P>0.05). 2. The pedicle screw system was more useful in reduction and its maintenance than the Luque ring system (P<0.001). 3. Redisplacement was occurred mainly within 2 months after operation, 4. The cause of redisplacement after reduction seems to be associated with mechanical insecurity before consolidation of the grafted bone takes place.
Decompression
;
Follow-Up Studies
;
Spondylolisthesis*
;
Transplants
7.A case of nucleus 22-channel cochlear implant.
Kwang Ryun KO ; Hee Wan PARK ; Hee Yoon KOO ; Kwang Ik KO ; Seong Soo BAN ; Seong Hyun CHO ; Yoon Hee PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(6):1327-1337
No abstract available.
Cochlear Implants*
8.Taxol-induced Pathological Findings in Rat Small Intestine.
Sun Hee CHANG ; Shi Nae LEE ; Hee Soo YOON ; Min Sun CHO ; Hea Soo KOO ; Woon Sup HAN
Korean Journal of Pathology 1997;31(12):1291-1296
Taxol is an active chemotherapeutic agent against a variety of solid tumors and a potentially useful drug for augmenting the cytotoxic action of radiotherapy against certain cancers. Taxol blocks cells in the mitotic phase of cell cycle. The aim of this study was to define the in vivo response of rapidly dividing cells of the small intestinal mucosa to taxol. We studied the numbers of apoptotic and mitotic cells and the expression of bcl-2 and p53 in rat jejunal crypt cells at 1, 2, 4, 8, 12, 16, and 24 hours and 3 and 5 days after intraperitoneal injection of taxol. Mitosis peaked at 2 and 4 hours and 12 and 16 hours. Apoptosis peaked at 16 hours and returned to normal after five days. The glands in crypts showed marked distortion with atypical lining cells after three days, which returned to normal at 5 days. bcl-2 expression was markedly decreased at 8 to 24 hours and subnormally recovered after three to five days. p53 showed no significant changes throughout. The histopathological changes in small intestine due to taxol were transient with complete recovery. bcl-2 expression was inversely corresponded to numbers of apoptosis. The changes were p53 independent. Further studies to understand the conditions that maximize the cell-cycle modulating effects of taxol cl-may greatly enhance its anti-tumor effectiveness.
Animals
;
Apoptosis
;
Cell Cycle
;
Injections, Intraperitoneal
;
Intestinal Mucosa
;
Intestine, Small*
;
Mitosis
;
Paclitaxel
;
Radiotherapy
;
Rats*
9.Anatomical measurements of the paranasal sinuses using PNS CT.
Hee Yoon KOO ; Kwang Ik KO ; Sung Su BAN ; Keum Suk KO ; Hee Wan PARK ; Kwang Ryun KO
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(5):966-971
No abstract available.
Paranasal Sinuses*
10.A Phase 2 Trial of PEF ( Cispatin , Etoposide , 5-Fluorouracil ) Chemotherapy for Metastatic Stomach Cancer.
Yoon Koo KANG ; Kwang Seob YUM ; Hee Jun CHO ; Jhin Oh LEE ; Taik Koo YUN
Journal of the Korean Cancer Association 1998;30(5):900-906
PURPOSE: To determine the activity and toxicities of PEF (Cisplatin, Etoposide, 5-Fluorouracil) chemotherapy for stomach cancer. MATERIALS AND METHODS: Patients with previously untreated metastatic stomach cancer were treated with PEF regimen which consisted of cisplatin (20 mg/m2 i.v. days 1~5), etoposide (100 mg/m2 i.v. days 1, 3, 5), and 5-fluorouracil (5-FU)(800 mg/m2 i.v. infusion for 12 hours days 1~5). Chemotherapy was repeated every 3 weeks until disease progressed or toxicities were intolerable. RESULTS: Between May 1989 and July 1990, 40 patients were enrolled in this protocol. Twelve patients were lost to follow up after one cycle of chemotherapy and inevaluable. After 2~8 cycles (median 3) of chemotherapy, 20 out of 28 evaluable patients showed objective responses without any complete response, making the response rate 71% (95% confidence interval: 54~89%). The responses lasted from 4+ to 39 weeks (median: 38 weeks). The overall survival of total evaluable patients was 4+ ~50+ weeks (median 38 weeks). Among total 109 cycles of chemotherapy, cycles were delayed or doses were reduced in 48 cycles (44%) because of leukopenia (in 61 cycles: 56%) and/or thrombocytopenia (in 14 cycles: 13%). However, there was no treatment-related death. Nausea/vomiting and alopecia were experienced in most of patients. The stomatitis was experienced in 7 patients (25%) but completely reversible. In contrast, the peripheral neuropathy which developed in 4 patients (14%) after 5 cycles of chemotherapy was not reversible. CONCLUSION: The PEF regimen was active and tolerable in stomach cancer.
Alopecia
;
Cisplatin
;
Drug Therapy*
;
Etoposide*
;
Fluorouracil*
;
Humans
;
Leukopenia
;
Lost to Follow-Up
;
Peripheral Nervous System Diseases
;
Stomach Neoplasms*
;
Stomach*
;
Stomatitis
;
Thrombocytopenia